Table 4.
Open in new tab

Association Between HDL-C and Cause-Specific Mortality

HDL-C Concentration, mg/dLCardiovascular MortalityNoncardiovascular Mortality
Deaths/nHR (95% CI)aPDeaths/nHR (95% CI)P
<3033/2452.86 (1.77–4.62)<0.00151/2451.57 (1.08–2.26)0.016
30–39127/13301.77 (1.21–2.58)0.293279/13301.44 (1.10–1.88)0.008
40–49206/20041.82 (1.28–2.61)0.001320/20041.21 (0.93–1.56)0.154
50–59142/18101.47 (1.02–2.21)0.397279/18101.27 (0.98–1.64)0.073
60–6978/12151.17 (0.79–1.74)0.433176/12151.17 (0.89–1.53)0.200
70–7936/6531.00 (reference)–76/6531.00 (reference)–
80–8930/3221.73 (1.07–2.82)0.02649/3221.35 (0.94–1.93)0.104
≥9013/1871.62 (0.86–3.05)0.13826/1871.45 (0.93–2.27)0.111
HDL-C Concentration, mg/dLCardiovascular MortalityNoncardiovascular Mortality
Deaths/nHR (95% CI)aPDeaths/nHR (95% CI)P
<3033/2452.86 (1.77–4.62)<0.00151/2451.57 (1.08–2.26)0.016
30–39127/13301.77 (1.21–2.58)0.293279/13301.44 (1.10–1.88)0.008
40–49206/20041.82 (1.28–2.61)0.001320/20041.21 (0.93–1.56)0.154
50–59142/18101.47 (1.02–2.21)0.397279/18101.27 (0.98–1.64)0.073
60–6978/12151.17 (0.79–1.74)0.433176/12151.17 (0.89–1.53)0.200
70–7936/6531.00 (reference)–76/6531.00 (reference)–
80–8930/3221.73 (1.07–2.82)0.02649/3221.35 (0.94–1.93)0.104
≥9013/1871.62 (0.86–3.05)0.13826/1871.45 (0.93–2.27)0.111
a

Adjusted for age, sex, race, educational level, current smoking status, alcohol consumption, regular exercise, BMI, household income, TC level, CRP level, HbA1c, hypertension, heart disease, stroke, cancer, diabetes, lung disease, psychiatric problems, and limitations in ADLs .

Table 4.
Open in new tab

Association Between HDL-C and Cause-Specific Mortality

HDL-C Concentration, mg/dLCardiovascular MortalityNoncardiovascular Mortality
Deaths/nHR (95% CI)aPDeaths/nHR (95% CI)P
<3033/2452.86 (1.77–4.62)<0.00151/2451.57 (1.08–2.26)0.016
30–39127/13301.77 (1.21–2.58)0.293279/13301.44 (1.10–1.88)0.008
40–49206/20041.82 (1.28–2.61)0.001320/20041.21 (0.93–1.56)0.154
50–59142/18101.47 (1.02–2.21)0.397279/18101.27 (0.98–1.64)0.073
60–6978/12151.17 (0.79–1.74)0.433176/12151.17 (0.89–1.53)0.200
70–7936/6531.00 (reference)–76/6531.00 (reference)–
80–8930/3221.73 (1.07–2.82)0.02649/3221.35 (0.94–1.93)0.104
≥9013/1871.62 (0.86–3.05)0.13826/1871.45 (0.93–2.27)0.111
HDL-C Concentration, mg/dLCardiovascular MortalityNoncardiovascular Mortality
Deaths/nHR (95% CI)aPDeaths/nHR (95% CI)P
<3033/2452.86 (1.77–4.62)<0.00151/2451.57 (1.08–2.26)0.016
30–39127/13301.77 (1.21–2.58)0.293279/13301.44 (1.10–1.88)0.008
40–49206/20041.82 (1.28–2.61)0.001320/20041.21 (0.93–1.56)0.154
50–59142/18101.47 (1.02–2.21)0.397279/18101.27 (0.98–1.64)0.073
60–6978/12151.17 (0.79–1.74)0.433176/12151.17 (0.89–1.53)0.200
70–7936/6531.00 (reference)–76/6531.00 (reference)–
80–8930/3221.73 (1.07–2.82)0.02649/3221.35 (0.94–1.93)0.104
≥9013/1871.62 (0.86–3.05)0.13826/1871.45 (0.93–2.27)0.111
a

Adjusted for age, sex, race, educational level, current smoking status, alcohol consumption, regular exercise, BMI, household income, TC level, CRP level, HbA1c, hypertension, heart disease, stroke, cancer, diabetes, lung disease, psychiatric problems, and limitations in ADLs .

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close